...
首页> 外文期刊>Hepatitis Monthly >OCCULT HEPATITIS C VIRUS INFECTION IN CANDIDATES FOR LIVER TRANSPLANT WITH CRYPTOGENIC CIRRHOSIS
【24h】

OCCULT HEPATITIS C VIRUS INFECTION IN CANDIDATES FOR LIVER TRANSPLANT WITH CRYPTOGENIC CIRRHOSIS

机译:低温致病性肝移植候选肝中的丙型肝炎病毒感染。

获取原文
           

摘要

Background: Occult hepatitis C virus (HCV) infection is a new entity described by the presence of HCV-RNA in liver biopsy and/or peripheral blood mononuclear cell (PBMC) specimens, and undetectable levels or absence of HCV-RNA and in the absence or presence of anti HCV antibodies in plasma by current laboratory methods.Objectives: To evaluate the detection of HCV-RNA in PBMC specimens of the liver transplant candidates with cryptogenic cirrhosis by reverse transcriptase-nested polymerase chain reaction (RT-nested PCR).Patients and Methods: From November 2007 to March 2013, 45 patients from Liver Transplant Center of Imam Khomeini Hospital, Tehran, were enrolled in this cross sectional study. PBMC specimens were separated from the peripheral blood sample. After extraction of RNA from plasma and PBMC specimens, HCV-RNA status was tested by RT-nested PCR. The 5?-untranslated region (5?-UTR) genotyping of HCV-RNA amplified from PBMC specimens was performed by a standard methodology with the INNO-LiPATM HCV II kit. The PCR products of 5?-UTR were sequenced after cloning into the pJET1.2 / blunt cloning vector.Results: Of 45 patients, 4 (8.9% [95% CI: 4.4-15.6]) had detectable genomic HCV-RNA in their PBMC specimens. HCV genotypes were determined in the PBMCs of these subjects showed that 2 (50.0%) subjects with occult HCV infection had HCV subtype 3a, and 2 (50.0%) had HCV subtype 1b.Conclusions: This study found that 8.9 % of the Iranian candidates for liver transplant with cryptogenic cirrhosis had occult HCV infection. Therefore, designing prospective studies focusing on the diagnosis of occult HCV infection in these subjects prior to liver transplantation could be valuable.
机译:背景:隐匿性丙型肝炎病毒(HCV)感染是一种新的疾病,其特征是肝活检和/或外周血单个核细胞(PBMC)标本中存在HCV-RNA,并且无法检测到或未检测到HCV-RNA的水平目的:通过逆转录酶巢式聚合酶链反应(RT巢式PCR)评估在隐源性肝硬化候选肝移植患者的PBMC标本中检测HCV-RNA的方法。方法:从2007年11月至2013年3月,来自德黑兰伊玛目霍梅尼医院肝移植中心的45例患者参加了本横断面研究。从外周血样品中分离出PBMC标本。从血浆和PBMC标本中提取RNA后,通过RT巢式PCR检测HCV-RNA的状态。从PBMC标本中扩增出的HCV-RNA的5′-非翻译区(5α-UTR)基因型通过INNO-LiPATM HCV II试剂盒的标准方法进行。克隆到pJET1.2 /平端克隆载体后,对5′-UTR的PCR产物进行了测序。结果:45例患者中,有4例(8.9%[95%CI:4.4-15.6])的基因组HCV-RNA可检测PBMC标本。在这些受试者的PBMC中确定了HCV基因型,结果表明2名(50.0%)隐性HCV感染的受试者患有HCV 3a亚型,而2名(50.0%)患有HCV亚型1b。结论:本研究发现8.9%的伊朗候选人对于隐源性肝硬化的肝移植患者有隐匿性HCV感染。因此,针对肝脏移植前这些受试者隐匿性HCV感染的诊断进行前瞻性研究可能是有价值的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号